In a mouse model of lung cancer, the combinatorial delivery of the pro-inflammatory miR-125b mimic together with wt-p53 cells using CD44/epidermal growth factor receptor (EGFR)-targeted hyaluronic acid-based nanoparticles repolarized TAMs towards the M1 phenotype and inhibited tumor growth [91]. Here, CD44 is linked to neoplasm.